SF3B1 and myelodysplastic syndrome: In MDS carrying mutations of the SF3B1 gene, there is also increased erythroid apoptosis due to impaired GATA-1 expression and end-stage erythroid maturation arrest attributed to EIF2AK1 activation (157, 158).